CEEZEX

This brand name is authorized in Nigeria.

Active ingredients

The drug CEEZEX contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII O1R9FJ93ED - CEFUROXIME
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5740	Powder for injection	Ceezex 1500 Powder for Injection INJ_PWD 1500 mg	Powder for solution for injection in vial Each vial contains: Cefuroxime Sodium equiv. to anhydrous Cefuroxime 1500 mg	07/05/2021
B4-5741	Tablet	Ceezex 500 TAB 500 mg	Film-coated tablet Each tablet contains: Cefuroxime Axetil (Amorphous) USP equiv. to Cefuroxime 500 mg	07/05/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5740, B4-5741